Downstream Processing Market Growth Forecast by Product Type (Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers), Technique (Cell Disruption, Solid-Liquid Separation, Concentration, Purification by Chromatography, Formulation), Application (Antibiotic Production, Hormone Production, Antibodies Production, Enzyme Production, Vaccine Production) – Global Industry Revenue Outlook Through 2030

Market Overview

The global downstream processing market revenue was valued at $21.1 billion in 2021, which is projected to advance at a CAGR of 10.3% during 2021–2030, to reach $51.0 billion by 2030. This is ascribed to factors such as the biotechnology sector expanding globally, rapid rise in R&D investment in the biopharmaceutical sector, and contract manufacturing organizations gaining significance. Furthermore, there have been incredible opportunities in the biotechnology industry, which have accelerated the expansion of the market on a global level.

Moreover, the rising demand for bioproducts, the growing adoption of biotech processes in the agricultural, pharmaceutical, and bio-services industries, the increasing adoption of single-use technology in bioprocessing, the surging advancements in the fields of gene therapy and genetic engineering, and the growing commercial success of biopharma companies are all contributing to the market growth. In addition, the increasing patent expiration of prominent biopharmaceuticals will generate new possibilities for the downstream processing industry throughout the forecast period.

Antibodies Production Category To Witness Fastest Growth

The antibodies production category is expected to witness the fastest growth, advancing at a CAGR of around 10.9%, in the coming years, based on application. Because of the increased need for monoclonal antibodies (mAb), the demand for antibody manufacturing is surging at the highest rate. The introduction of new products for the effective purification of antibodies also drives the market growth in this category. For instance, in January 2021, Cytiva introduced HiScreen Fibro PrismA for the purification and process development of mAb.

Furthermore, antibodies have been identified as one of the most prevalent modalities for biopharmaceutical companies. The development of innovative technologies, such as alternative expression systems, continuous ongoing biomanufacturing, and nonchromatographic separation formats, for bioprocessing antibodies has accelerated the market expansion.

Chromatography Systems Are the Largest Revenue Generator

The chromatography systems category led the market and accounted for the largest revenue share, of 37.5%, in 2021, based on product. Continuous R&D operations to increase the efficiency and speed of chromatography systems are expected to drive market development. For instance, in April 2021, Thermo Fisher Scientific introduced the HyPeak chromatography system for bioprocessing, with important applications in therapeutic protein and vaccine production. Therefore, an increase in chromatographic system deals and innovations also augments the downstream processing market growth in this category.

The solid-liquid separation category is projected to witness the highest CAGR in the upcoming years. This is because the solid-liquid separation technique has various advantages, including cost-effectiveness, simplicity, and better-suited for continuous-mode production. Moreover, this type of filtration may also be easily applied to a wide range of pharmaceutical applications, due to its versatile nature.

Whereas, the purification by chromatography category accounted for the largest share in the market in 2021. This is ascribed to the high demand for extremely pure biopharmaceutical goods to fulfill regulatory standards, since downstream purification plays a vital role in improving product purity and quality, boosting the need for this purification technique.

Rapid Increase in R&D Efforts for Bioprocessing Technologies

As a result of the fast increase in R&D efforts relevant to advanced bioprocess technologies, high-throughput process development, perfusion chromatography systems, and continuous downstream processing systems for multicomponent separations, the high-resolution membrane systems have been widely adopted. This has led to the rise in the demand for better and advanced bioprocessing technologies for addressing the purification of a bottleneck.

The number of CMOs in the downstream processing industry has grown, as outsourcing assists pharmaceutical producers in lowering expensive initial capital investments and procedure expenses. In addition to cell culture preparation, chromatography, mixing, concentration, process monitoring, and disposable technologies, CMOs assist drug manufacturers in enhancing downstream purification processes. Conclusively, these factors are driving the downstream processing market growth.

Biopharmaceutical Commercial Success Drives the Need for Bioprocessing Innovation

Biopharmaceutical is one of the most promising areas in terms of future growth. Many healthcare organizations predict that this market will be one of the top 10 income sources in the coming years. Furthermore, corporations are making efforts to enhance their presence in this sector, in order to fulfill the rising demand for bio-based medicines, which results in increased biopharma companies’ accessibility for clinical use.

This consistent commercial success of biological pharmaceuticals is projected to propel the bioprocessing industry forward over the forecast period. Previously, only a few companies could handle the complete value chain of biologic manufacturing. This has changed considerably in recent years, since there are now multiple businesses in the market working in the development of biologics. Moreover, in recent years, the biological pharmaceutical business has expanded significantly to incorporate innovative product categories such as nanobody, rDNA, synthetic vaccine, fusion protein, soluble receptor, immunoconjugate, and immunotherapeutic. Therefore, the aforementioned factors are propelling the downstream processing market demand.

Explore more about this report - Request free sample pages

APAC Market To Experience Fastest Growth

APAC is projected to be the fastest-growing market and it would grow at a significant CAGR, of 10.8%, during the forecast period. This can be attributed to the improving R&D infrastructure, increasing expenditure made by market competitors, and rising government support.

On the other hand, North America led the market and accounted for the largest revenue share, of around 32.4%, in 2021. This is due to the rapid rise in government funding for bioprocess technologies, high medical costs, expanded healthcare infrastructure, and the presence of major market players in the region. Also, North America has seen involved in collaboration activities with healthcare behemoths that are heavily investing in the biopharma sector and vaccine R&D.

To Increase Market Share, Companies Involved in Product Launches and Acquisitions

The market is fragmented with the presence of several players. These players have been involved in launching new products and acquiring similar companies, in order to stay ahead of their competitors. For instance:

• In April 2022, Merck formed an alliance with the Wuxi National High-Tech Industrial Development Zone's administrative management board, to expand its single-use manufacturing site in Wuxi, China.
• In February 2022, Sartorius acquired Novasep's chromatography division. The portfolio purchased comprises chromatography systems built primarily for smaller biomolecules such as peptides, oligonucleotides, and insulin, as well as novel technologies for the continuous manufacture of biologics.
• In August 2021, Danaher Corp. acquired Aldevron. Within Danaher's Life Sciences segment, Aldevron operates as a separate operational business and brand.

Key Players in the Global Downstream Processing Market Are:

• GE Healthcare
• Thermo Fisher Scientific Inc.
• Sartorius Stedim Biotech S.A.
• Danaher Corporation
• Lonza Group Ltd.
• Dover Corporation
• Ferner PLC
• Eppendorf SE
• Repligen

Market Size Breakdown by Segment

The study offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.

Based on Product Type

• Chromatography Systems
• Filters
• Evaporators
• Centrifuges
• Dryers

Based on Technique

• Cell Disruption
• Solid-liquid separation
• Concentration
• Purification by Chromatography
• Formulation

Based on Application

• Antibiotic Production
• Hormone Production
• Antibodies Production
• Enzyme Production
• Vaccine Production

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • Italy
  • Spain
  • U.K.
• Asia-Pacific
  • China
  • Japan
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • South Africa
  • U.A.E.